Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cost estimation when time and resources are limited: the Brief DATCAP.

Michael T French1, M Christopher Roebuck, A Thomas McLellan

  • 1Department of Sociology, University of Miami, Coral Gables, FL 33124-2030, USA. mfrench@miami.edu

Journal of Substance Abuse Treatment
|October 27, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Spring Broken: A Risk Analysis of Fatal and Nonfatal Traffic Injuries in Florida.

Risk analysis : an official publication of the Society for Risk Analysis·2026
Same author

Goals for Opioid Use Disorder Medications - Protection, Remission, and Recovery.

The New England journal of medicine·2025
Same author

Is a Distressed Birth Associated With Physical and Mental Health Problems as an Adult?: Evidence From Panel Data.

Medical care·2025
Same author

Do Current and Lifetime Mental Health Issues Influence Subjective Social Status?

The journal of mental health policy and economics·2025
Same author

Use of alternative payment models for substance use disorder prevention in the United States: development of a conceptual framework.

Substance abuse treatment, prevention, and policy·2025
Same author

The price of progress: understanding innovation and affordability of prescription drugs.

The American journal of managed care·2024
Same journal

Call for commentaries on COVID-19.

Journal of substance abuse treatment·2024
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

TOC (update).

Journal of substance abuse treatment·2023
Same journal

A qualitative analysis of barriers to opioid agonist treatment for racial/ethnic minoritized populations.

Journal of substance abuse treatment·2022
Same journal

Factors associated with the adoption of evidence-based innovations by substance use disorder treatment organizations: A study of HIV testing.

Journal of substance abuse treatment·2022
See all related articles

A new, shorter version of the Drug Abuse Treatment Cost Analysis Program (DATCAP), called the Brief DATCAP, provides similar cost estimates to the original tool. This brief instrument is easier and faster for addiction researchers to use.

Area of Science:

  • Health Economics
  • Substance Abuse Research
  • Addiction Treatment

Background:

  • The Drug Abuse Treatment Cost Analysis Program (DATCAP) was developed in the early 1990s to guide financial data collection and analysis in addiction treatment programs.
  • A need exists for a more efficient version of DATCAP to reduce administrative burden without compromising cost estimate accuracy.

Purpose of the Study:

  • To introduce the Brief DATCAP, a shortened version of the DATCAP instrument.
  • To evaluate the feasibility, understandability, and accuracy of cost estimates generated by the Brief DATCAP compared to the original DATCAP.

Main Methods:

  • Development of the Brief DATCAP, a condensed version of the original DATCAP.
  • Administration of the Brief DATCAP to respondents and collection of feedback on usability.

Related Experiment Videos

  • Comparison of cost estimates derived from the Brief DATCAP against those from the full DATCAP.

    • Main Results:

    • Respondent feedback indicates the Brief DATCAP is understandable, easier, and quicker to complete.
    • Preliminary analysis shows cost estimates from the Brief DATCAP deviate by less than 2% from the full DATCAP estimates.
    • The Brief DATCAP demonstrates high fidelity to the original instrument's cost estimation capabilities.

    Conclusions:

    • The Brief DATCAP offers a viable alternative to the full DATCAP for economic evaluations of addiction interventions.
    • This shorter instrument enhances the feasibility and precision of future addiction treatment research.
    • The findings support the use of the Brief DATCAP in research and policy-making for addiction treatment programs.